WEE2 antibody

Synonyms:FLJ16107 antibody, WEE1 homolog 2(S. pombe) antibody, Wee1 like protein kinase 1B antibody, Wee1 like protein kinase 2 antibody, WEE1B antibody, Wee1B kinase antibody, WEE2 antibody
Catalogue No.:FNab09506Reactivity:Human
Host:RabbitTested Application:ELISA, WB
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
WEE2 antibody
Catalogue No.
FNab09506
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
WEE1 homolog 2(S. pombe)
Alternative Names
FLJ16107 antibody, WEE1 homolog 2(S. pombe) antibody, Wee1 like protein kinase 1B antibody, Wee1 like protein kinase 2 antibody, WEE1B antibody, Wee1B kinase antibody, WEE2 antibody
UniProt ID
P0C1S8
Observed MW
63 kDa
Application
Tested Applications
ELISA, WB
Recommended dilution
WB: 1:200-1:2000
Validated Images
Jurkat cells were subjected to SDS PAGE followed by western blot with FNab09506(WEE2 antibody) at dilution of 1:500
Background
Oocyte-specific protein tyrosine kinase that phosphorylates and inhibits CDK1 and acts as a key regulator of meiosis during both prophase I and metaphase II. Required to maintain meiotic arrest in oocytes during the germinal vesicle(GV) stage, a long period of quiescence at dictyate prophase I, by phosphorylating CDK1 at 'Tyr-15', leading to inhibit CDK1 activity and prevent meiotic reentry. Also required for metaphase II exit during egg activation by phosphorylating CDK1 at 'Tyr-15', to ensure exit from meiosis in oocytes and promote pronuclear formation(By similarity).